29.02.2024 • News

ICL Acquires Brazilian Biologicals Specialist Nitro 1000

ICL is to acquired Nitro 1000, a Brazilian manufacturer, developer and provider of biologicals for approximately $30 million.

Tel-Aviv, Israel headquartered ICL said that Nitro 1000 will immediately join its product portfolio, and the company will begin selling to its existing customer base in Brazil. Nitro 1000’s products are mainly aimed at soybean, corn and sugar cane crops, and their application replaces or optimizes the use of fertilizers. Biologicals stimulate natural processes to enhance or benefit nutrient uptake, nutrient use efficiency, abiotic stress tolerance, and crop quality and yield.

“We’re excited to merge Nitro 1000’s core expertise in biologicals manufacturing with ICL’s extensive R&D capabilities and innovation engine and to further execute against our stated strategy of continuing to invest in agriculture – specifically in Brazil,” said Elad Aharonson, president of ICL Growing Solutions.

According to ICL, increasing interest in alternatives to agrochemicals has created higher demand for biologicals solutions, and the agrochemical biologicals market is expected to grow at a 13.8% CAGR and reach $27.9 billion by 2028.

In Brazil, ICL currently has more than 1,700 employees, and the country represented approximately 20% of sales in 2023.

“We founded Nitro 1000 in 2007 and made the necessary investments to develop our products and reach this point on our journey,” said Iris Guindani, one of the founders of Nitro 1000, who will remain as head of operations. “This next phase will allow us to leverage ICL's resources, including its robust R&D capabilities, to develop additional new products and target adjacent end-markets,” Guindani added.

© Shutterstock / Tricky_Shark
© Shutterstock / Tricky_Shark

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.